icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Seattle, Washington
Feb 19-22 2023
Back grey_arrow_rt.gif
 
 
 
Remdesivir Retains Potent Antiviral
Activity Against SARS-CoV-2 Variants of Concern
 
 
  CROI 2023
 
Lauren Rodriguez,1 Tien-Ying Hsiang,2 Jiani Li,1 Dong Han,1 Jasmine Moshiri,1 Xianghan Lu,1 Ross Martin,1 Nicholas C. Riola,1 Jared Pitts,1 Jason K. Perry,1 John P. Bilello,1 Michael Gale Jr.,2 Danielle P. Porter,1 Charlotte Hedskog1,* 1Gilead Sciences, Inc., Foster City, CA, USA; 2University of Washington, Seattle, WA, USA.

0322231

0322232

0322233

0322234

0322235

0322236

0322237

0322238

0322239

03222310

03222311